NCODA is proud to announce that Barbara McAneny, MD, FASCO, MACP will be joining our Legislative & Policy Advisory Committee (LPAC). Dr. McAneny is the CEO of New Mexico Oncology Hematology Consultants. Dr. McAneny was also elected by the American Medical Association House of Delegates and served as AMA President from 2018 – 2019.

“NCODA has a remarkable opportunity to make life better for cancer patients – and any patients who need assistance,” said McAneny. “Having NCODA’s voice adding to the discussion on all oncology legislative issues is just what we need right now. I am honored to be a part of LPAC.”

Dr. McAneny is an advocate for legislative reform and advancing quality care for cancer patients. She has testified three times before Congress on issues of vital importance to oncology healthcare professionals. She is a nationally recognized and sought-after speaker on innovative practice design and complex health care delivery systems.

“The goal of LPAC and all of our legislative efforts is to innovative and provide the most up-to-date information, resources and insight,” said Kevin Scorsone, NCODAs Legislative & Policy Liaison. “Having Dr. McAneny join LPAC positions the Committee well to meet and exceed these goals. She is a tremendous addition to the Committee.”

NCODA is focused on growing our legislative efforts and adding dedicated, patientcentered individuals to our Committee that will help continue the growth of our efforts and make NCODA the go-to resource for all legislative oncology materials.